Melanoma Surveillance in the US: Melanoma, Ultraviolet Radiation, and Socioeconomic Status

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this podcast from the Centers for Disease Control and Prevention, Chris Johnson, from the Cancer Data Registry of Idaho, discusses the results of several studies published in a supplement to the November 2011 edition of the Journal of the American Academy of Dermatology that examined the relationship between rates of melanoma and 2 variables recorded at the county level: ultraviolet radiation and socioeconomic status.
 
To listen to the podcast, click here.
Related Articles
The FDA is considering approval for a liquid bendamustine hydrochloride rapid infusion product.
The FDA has granted priority review status to Amgen’s supplemental New Drug Application for its carfilzomib (Kyprolis) cancer therapy.
Teikoku Pharma USA has submitted a New Drug Application to the FDA for the product.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$